MT Højgaard Holding A/S
MT Højgaard Holding A/S: MT Højgaard Danmark to build domicile for Grundfos
MT Højgaard Holding A/S: MT Højgaard Danmark to build domicile for Grundfos
MT Højgaard Holding’s business unit MT Højgaard Danmark has entered into an agreement with Grundfos for the construction of a new 13,000 sqm domicile in Bjerringbro.
In 2023, MT Højgaard Danmark entered into a preliminary contract for the assignment, which was conditional, i.a., on district planning changes. This contract is now unconditional.
The new five-storey domicile will accommodate 660 employees, and the building will be part of a joint campus, which Grundfos is planning for the area. It is the ambition to ensure that the new domicile has as low a climate footprint as possible, and it is the plan to have the building certified at the DGNB Platin level while ensuring compliance with LEED Platinum requirements. The building is designed by AART architects with Niras acting as engineering consultant.
The construction works will commence in Q1 2025 with expected handover in Q2 2027.
”We are pleased that we have been selected to construct Grundfos’ new domicile, where our own production, including within foundations, shell structures, and soil and concrete, will play a key role in the construction process. The project has been in process for a long period of time, and we are proud to be able to add this to our order book. We are looking forward to a close cooperation with Grundfos on the project,” says Carsten Lund, CEO of MT Højgaard Danmark.
The order is expected to contribute positively to MT Højgaard Holding’s 2025 outlook, which will be announced in the annual report on 20 February 2025.
Further information:
CEO Rasmus Untidt and CFO Dennis Nørgaard can be contacted on telephone +45 31 21 68 72.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S22.6.2025 21:35:25 CEST | Press release
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
Bitget Limited22.6.2025 17:32:39 CEST | Press release
Bitget Partners with MotoGP for a High-Speed Collision of Tech and Speed
Novo Nordisk A/S22.6.2025 15:00:30 CEST | Press release
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Ministry of Information & Broadcasting, Pakistan21.6.2025 15:18:54 CEST | Press release
Government of Pakistan Recommends President Donald J. Trump for 2026 Nobel Peace Prize
1000 Miglia S.r.l.21.6.2025 14:15:41 CEST | Press release
1000 MIGLIA 2025, the fifth and final leg has started
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom